FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1889701541> ?p ?o ?g. }

• W1889701541 endingPage "538" @default.
• W1889701541 startingPage "513" @default.
• W1889701541 abstract "On March 23, 2010, President Obama signed into law the Biologics Price Competition and Innovation Act of 2009 ('BPCIA') to create an abbreviated approval pathway for generic 'biological products' that are demonstrated to be highly similar (i.e., biosimilar) to or interchangeable with an FDA-licensed reference biological product. The BPCIA is intended to reap cost savings for patients by creating a means for the production, use and sale of follow-on biologic therapeutics in the United States. The BPCIA's intellectual property provisions are modeled in part, after the Drug Price Competition and Patent Term Restoration Act of 1984 (i.e., the 'Hatch-Waxman' Act) pursuant to which generic versions of branded drugs, namely, chemically synthesized small-molecule products, have been approved by permitting appropriate reliance on what is already known about a drug, thereby saving time and resources and avoiding unnecessary duplication of human or animal testing. Like the Hatch-Waxman Act, the BPCIA provides for the establishment of a form of proprietary rights that are distinct from patent rights, sometimes termed 'data exclusivity' or 'data protection', that consist of a period of time during which the USFDA affords an approved drug protection from competing applications for marketing approval and restricts generic competitors' ability to reference the data generated by the manufacturers of brand-name drugs. Important technical differences, nevertheless, exist between traditional pharmaceuticals and biologic drugs that significantly drive up research and development, regulatory market authorization and product marketing costs. To recoup these greater expenditures, the BPCIA has provided correspondingly longer periods of marketing/data exclusivities to original biologic drugs - generally twelve years instead of five years under Hatch-Waxman - to protect clinical testing data and other proprietary and confidential (trade secret) information generated by an original brand-name drug developer to obtain a biologic license. The BPCIA's longer twelve-year exclusivity period, however, has continued to generate considerable post-enactment debate among healthcare activists, academicians, brand name and generic pharmaceutical manufacturers, and U.S. congressional representatives, which compromises U.S. bilateral and regional trade relations, and potentially impairs the competitiveness of the U.S. biopharmaceutical industry and the economic value of such companies' IP assets. Until recently, public opposition to the BPCIA's twelve-year exclusivity period and patent provisions had frustrated Obama administration efforts to both secure congressional ratification of the previously signed and modified bilateral Korea-U.S. Free Trade Agreement and to successfully advance a favorable U.S. negotiating position that guarantees strong patent and marketing/data exclusivity protections at recent Trans-Pacific Partnership Agreement negotiating sessions." @default.
• W1889701541 created "2016-06-24" @default.
• W1889701541 creator A5068731286 @default.
• W1889701541 date "2011-11-01" @default.
• W1889701541 modified "2023-09-26" @default.
• W1889701541 title "The U.S. Biologics Price Competition and Innovation Act of 2009 Triggers Public Debates, Regulatory/Policy Risks, and International Trade Concerns" @default.
• W1889701541 doi "https://doi.org/10.54648/gtcj2011065" @default.
• W1889701541 hasPublicationYear "2011" @default.
• W1889701541 type Work @default.
• W1889701541 sameAs 1889701541 @default.
• W1889701541 citedByCount "4" @default.
• W1889701541 countsByYear W18897015412013 @default.
• W1889701541 countsByYear W18897015412015 @default.
• W1889701541 countsByYear W18897015412018 @default.
• W1889701541 countsByYear W18897015412020 @default.
• W1889701541 crossrefType "journal-article" @default.
• W1889701541 hasAuthorship W1889701541A5068731286 @default.
• W1889701541 hasConcept C100001284 @default.
• W1889701541 hasConcept C108759981 @default.
• W1889701541 hasConcept C127576917 @default.
• W1889701541 hasConcept C144133560 @default.
• W1889701541 hasConcept C150903083 @default.
• W1889701541 hasConcept C162324750 @default.
• W1889701541 hasConcept C162853370 @default.
• W1889701541 hasConcept C17744445 @default.
• W1889701541 hasConcept C18903297 @default.
• W1889701541 hasConcept C190253527 @default.
• W1889701541 hasConcept C199539241 @default.
• W1889701541 hasConcept C2524010 @default.
• W1889701541 hasConcept C2777589142 @default.
• W1889701541 hasConcept C33923547 @default.
• W1889701541 hasConcept C34974158 @default.
• W1889701541 hasConcept C38652104 @default.
• W1889701541 hasConcept C40700 @default.
• W1889701541 hasConcept C41008148 @default.
• W1889701541 hasConcept C59491497 @default.
• W1889701541 hasConcept C60644358 @default.
• W1889701541 hasConcept C74676461 @default.
• W1889701541 hasConcept C86803240 @default.
• W1889701541 hasConcept C90673727 @default.
• W1889701541 hasConcept C91306197 @default.
• W1889701541 hasConceptScore W1889701541C100001284 @default.
• W1889701541 hasConceptScore W1889701541C108759981 @default.
• W1889701541 hasConceptScore W1889701541C127576917 @default.
• W1889701541 hasConceptScore W1889701541C144133560 @default.
• W1889701541 hasConceptScore W1889701541C150903083 @default.
• W1889701541 hasConceptScore W1889701541C162324750 @default.
• W1889701541 hasConceptScore W1889701541C162853370 @default.
• W1889701541 hasConceptScore W1889701541C17744445 @default.
• W1889701541 hasConceptScore W1889701541C18903297 @default.
• W1889701541 hasConceptScore W1889701541C190253527 @default.
• W1889701541 hasConceptScore W1889701541C199539241 @default.
• W1889701541 hasConceptScore W1889701541C2524010 @default.
• W1889701541 hasConceptScore W1889701541C2777589142 @default.
• W1889701541 hasConceptScore W1889701541C33923547 @default.
• W1889701541 hasConceptScore W1889701541C34974158 @default.
• W1889701541 hasConceptScore W1889701541C38652104 @default.
• W1889701541 hasConceptScore W1889701541C40700 @default.
• W1889701541 hasConceptScore W1889701541C41008148 @default.
• W1889701541 hasConceptScore W1889701541C59491497 @default.
• W1889701541 hasConceptScore W1889701541C60644358 @default.
• W1889701541 hasConceptScore W1889701541C74676461 @default.
• W1889701541 hasConceptScore W1889701541C86803240 @default.
• W1889701541 hasConceptScore W1889701541C90673727 @default.
• W1889701541 hasConceptScore W1889701541C91306197 @default.
• W1889701541 hasIssue "Issue 11/12" @default.
• W1889701541 hasLocation W18897015411 @default.
• W1889701541 hasOpenAccess W1889701541 @default.
• W1889701541 hasPrimaryLocation W18897015411 @default.
• W1889701541 hasRelatedWork W1485183875 @default.
• W1889701541 hasRelatedWork W1889701541 @default.
• W1889701541 hasRelatedWork W1986849176 @default.
• W1889701541 hasRelatedWork W2096139067 @default.
• W1889701541 hasRelatedWork W2946696866 @default.
• W1889701541 hasRelatedWork W3120439107 @default.
• W1889701541 hasRelatedWork W3122009876 @default.
• W1889701541 hasRelatedWork W394616214 @default.
• W1889701541 hasRelatedWork W4205537124 @default.
• W1889701541 hasRelatedWork W4307327402 @default.
• W1889701541 hasVolume "6" @default.
• W1889701541 isParatext "false" @default.
• W1889701541 isRetracted "false" @default.
• W1889701541 magId "1889701541" @default.
• W1889701541 workType "article" @default.